GL1X · GenesisL1 explorer

MolNFT v1 · #189326 · protein

Cryo-EM structure of human ntcp complexed with YN69202FAB

7VAD · SODIUM/BILE acid cotransporter: “Cryo-EM structure of human ntcp complexed with YN69202FAB”. Electron microscopy, 11 pockets (best druggability 0.71). MolNFT v1 #189326 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7VAD
Type
protein
Length
743 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SODIUM/BILE acid cotransporter; Fab heavy chain from antibody IgG clone number YN69202…
UniProt
Q14973
Pockets
11 · best druggability 0.71

Structure

electron microscopy · 3 distinct chains · 33% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASODIUM/BILE acid cotransporterprotein30676% helix, 0% strandQ14973
HFab heavy chain from antibody IgG clone number YN69202protein2213% helix, 45% strand—
LFab light chain from antibody IgG clone number YN69202protein2162% helix, 40% strand—

Pockets

11 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18020.710.7657empty
22460.580.7940empty
31720.560.8026empty
43120.560.7635empty
51330.510.7913empty

Interfaces

3 interfaces between chains.

  • H–L · 1786 Ų buried · 11 hydrogen bonds · protein-protein
  • A–H · 782 Ų buried · 14 hydrogen bonds · protein-protein
  • A–L · 446 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 7VAD · Cryo-EM structure of human NTCP complexed with YN69202Fab · the same entry in another collection · chain A against A, TM-score 1.00
  • Q14973 · AlphaFold monomer V2.0 prediction for SODIUM/BILE acid cotransporter (Q14973) · a predicted model of the same protein · chain A against A, TM-score 0.79

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.